Replies to post #782004 on NorthWest Biotherapeutics Inc (NWBO)

[RobotDroid]

And no ASM this year since the mute inept crew of cowards can't face SH with nothing but bad news, dilution, and the never ending grift.

[Investor082]

Agreed. Also tells you that no big pharma is interested in licensing L for commercialization. Otherwise, why talk about L compassionate use in USA?

And as you say, why not just apply for US FDA approval. 5 years since data lock and counting….

Not to mention, the most lucrative market with over 50% of the world’s immunotherapy revenue concentrated in one region! In contrast, UK is less than 5%!